CLINICAL_TRIALS
trial_result
· 2024-05-30
Clinical Trial Update: Vascular Endothelial Growth Factor in Stage V ROP [Phase 4]
Summary
A Phase 4 trial investigating vascular endothelial growth factor for Stage V retinopathy of prematurity has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Retinopathy of Prematurity | Phase 4 | Status: TERMINATED